| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $13.7B | $10.7B | $8.6B | $6.6B | $4.9B | $2.9B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | $1.4B | $1.2B | $1.0B | $0.8B | $0.4B | $0.3B |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | $0.7B | $-0.0B | $-0.6B | $-1.1B | $-0.5B | $-0.4B |
| Net Income | $0.9B | $0.1B | $-0.6B | $-1.4B | $-0.5B | $-0.5B |
| EPS (Basic) | $2.19 | $0.30 | $-1.42 | $-3.68 | $-1.39 | — |
| EPS (Diluted) | $2.13 | $0.29 | $-1.42 | $-3.68 | $-1.39 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $19.7B | $12.8B | $10.8B | $9.8B | $6.8B | $6.4B |
| Current Assets | $8.6B | $7.4B | $5.6B | $4.7B | $4.6B | $5.5B |
| Cash & Equivalents | $4.4B | $4.0B | $2.7B | $2.0B | $2.5B | $4.3B |
| Total Liabilities | $9.6B | $5.0B | $4.0B | $3.0B | $2.1B | $1.7B |
| Current Liabilities | $6.1B | $4.4B | $3.4B | $2.5B | $1.8B | $1.4B |
| Stockholders' Equity | $10.0B | $7.8B | $6.8B | $6.8B | $4.7B | $4.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.4B | $2.1B | $1.7B | $0.4B | $0.7B | $0.3B |
| Investing Cash Flow | $-4.4B | $-0.4B | $-0.3B | $-0.3B | $-2.0B | $-0.2B |
| Capital Expenditures | $0.3B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B |
| Financing Cash Flow | $2.4B | $-0.2B | $-0.8B | $-0.4B | $-0.5B | $4.0B |